SE441526B - N-/3-(merkaptoacetylamino)bensoyl/glycin och farmaceutiskt godtagbara salter derav samt anvendning derav for likvefaktion av slem in vitro - Google Patents

N-/3-(merkaptoacetylamino)bensoyl/glycin och farmaceutiskt godtagbara salter derav samt anvendning derav for likvefaktion av slem in vitro

Info

Publication number
SE441526B
SE441526B SE7806880A SE7806880A SE441526B SE 441526 B SE441526 B SE 441526B SE 7806880 A SE7806880 A SE 7806880A SE 7806880 A SE7806880 A SE 7806880A SE 441526 B SE441526 B SE 441526B
Authority
SE
Sweden
Prior art keywords
mercaptoacetylamino
benzoyl
glycine
salt
sodium
Prior art date
Application number
SE7806880A
Other languages
English (en)
Swedish (sv)
Other versions
SE7806880L (sv
Inventor
T A Martin
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE7806880L publication Critical patent/SE7806880L/xx
Publication of SE441526B publication Critical patent/SE441526B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7806880A 1977-06-15 1978-06-14 N-/3-(merkaptoacetylamino)bensoyl/glycin och farmaceutiskt godtagbara salter derav samt anvendning derav for likvefaktion av slem in vitro SE441526B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/806,877 US4093739A (en) 1977-06-15 1977-06-15 Mercaptoacylamidobenzoyl glycine and mucolytic process

Publications (2)

Publication Number Publication Date
SE7806880L SE7806880L (sv) 1978-12-16
SE441526B true SE441526B (sv) 1985-10-14

Family

ID=25195031

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7806880A SE441526B (sv) 1977-06-15 1978-06-14 N-/3-(merkaptoacetylamino)bensoyl/glycin och farmaceutiskt godtagbara salter derav samt anvendning derav for likvefaktion av slem in vitro

Country Status (21)

Country Link
US (2) US4093739A (enExample)
JP (1) JPS545933A (enExample)
AU (1) AU520094B2 (enExample)
BE (1) BE868114A (enExample)
CA (1) CA1132607A (enExample)
CH (1) CH635067A5 (enExample)
DE (1) DE2825931C2 (enExample)
DK (1) DK268478A (enExample)
ES (1) ES470825A1 (enExample)
FI (1) FI71307C (enExample)
FR (1) FR2394526A1 (enExample)
GB (1) GB2001958B (enExample)
GR (1) GR73530B (enExample)
IE (1) IE46995B1 (enExample)
IT (1) IT1107483B (enExample)
LU (1) LU79805A1 (enExample)
NL (1) NL7806360A (enExample)
PH (1) PH13512A (enExample)
SE (1) SE441526B (enExample)
YU (1) YU40195B (enExample)
ZA (1) ZA783443B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296500A (en) * 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
SE9103572D0 (sv) * 1991-11-29 1991-11-29 Astra Ab Organic salts of n,n'-diacetyl cystine
ES2148305T3 (es) * 1993-11-16 2000-10-16 Novartis Ag Derivados de aminoacidos ciclicos que tienen actividad inhibidora de ace y nep.
US5432186A (en) * 1993-11-16 1995-07-11 Ciba-Geigy Corporation Cyclic amino acid derivatives
US5451405A (en) * 1994-04-25 1995-09-19 Chesebrough-Pond's Usa Co. Skin treatment composition
JP3261969B2 (ja) * 1996-02-29 2002-03-04 豊田合成株式会社 ホースとその製造方法
US6294695B1 (en) * 1998-03-26 2001-09-25 Mount Sinai School Of Medicine Of The City University Of New York Aminobenzoic acid derivatives having anti-tumorigenic activity methods of making and using the same
JP2003106051A (ja) * 2001-09-28 2003-04-09 Tostem Corp サッシ
US6797319B2 (en) * 2002-05-31 2004-09-28 Kimberly-Clark Worldwide, Inc. Application of foam to tissue products using a liquid permeable partition
FI3678739T3 (fi) 2017-09-07 2024-05-21 Childrens Hospital Philadelphia Koostumuksia ja menetelmiä periytyvän kystatiini c -amyloidiangiopatian (hccaa) ja muiden poikkeaviin amyloidikertymiin liittyvien hermostoa rappeuttavien häiriöiden hoitoon

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2520293A (en) * 1947-01-30 1950-08-29 Endo Products Inc Mercaptoacetanilide derivatives
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
US3663690A (en) * 1969-08-12 1972-05-16 Hoechst Co American Mucolytic composition and method of treatment of broncho-pulmonary disorders therewith
BE789811A (fr) * 1971-10-07 1973-04-06 Bristol Myers Co 1,4-bis-acylpiperazines
BE789838A (fr) * 1971-10-13 1973-02-01 Cerm Cent Europ Rech Mauvernay Nouveaux derives de la cysteine et leur application en therapeutique
FR2187327B1 (enExample) * 1972-06-15 1975-06-20 Rech Pharm Scientifiques
US3971828A (en) * 1972-10-03 1976-07-27 Santen Pharmaceutical Co. Ltd. N-(mercaptoacyl)aminoacids
US3857951A (en) * 1973-09-14 1974-12-31 Cassenne Lab Sa Use of 2-mercaptopropionylglycine and its alkali metal salts in treating respiratory diseases
US4005222A (en) * 1975-05-21 1977-01-25 Mead Johnson & Company Mucolytic mercaptoacylamidobenzoic and benzenesulfonic acid compounds and process

Also Published As

Publication number Publication date
GB2001958B (en) 1982-02-03
IE781194L (en) 1978-12-15
FI71307B (fi) 1986-09-09
US4132803A (en) 1979-01-02
JPS6225657B2 (enExample) 1987-06-04
GB2001958A (en) 1979-02-14
AU520094B2 (en) 1982-01-14
JPS545933A (en) 1979-01-17
FI71307C (fi) 1986-12-19
YU40195B (en) 1985-08-31
AU3711278A (en) 1979-12-20
YU137578A (en) 1983-01-21
ZA783443B (en) 1979-06-27
FR2394526B1 (enExample) 1980-07-04
ES470825A1 (es) 1979-10-01
DE2825931A1 (de) 1979-01-04
NL7806360A (nl) 1978-12-19
US4093739A (en) 1978-06-06
GR73530B (enExample) 1984-03-12
CH635067A5 (de) 1983-03-15
BE868114A (fr) 1978-12-14
FR2394526A1 (fr) 1979-01-12
IE46995B1 (en) 1983-11-30
LU79805A1 (fr) 1979-02-02
SE7806880L (sv) 1978-12-16
IT1107483B (it) 1985-11-25
FI781866A7 (fi) 1978-12-16
DK268478A (da) 1978-12-16
DE2825931C2 (de) 1987-01-29
IT7849864A0 (it) 1978-06-14
CA1132607A (en) 1982-09-28
PH13512A (en) 1980-06-03

Similar Documents

Publication Publication Date Title
US4096277A (en) Mucolytic mercaptoacylamidobenzamides and process of using same
SE441526B (sv) N-/3-(merkaptoacetylamino)bensoyl/glycin och farmaceutiskt godtagbara salter derav samt anvendning derav for likvefaktion av slem in vitro
AU2010250920B2 (en) Disaccharin, difumaric acid, di-l-hydroxy-2-naphthoic acid and mono-benzoic acid salts of 4- (dimethylamin0)butyl 2- (4- ( (2-amino-4-methyl-6- (pentylamino) pyrimidin- 5 -yl) methyl) phenyl)acetate
JP2022501327A (ja) イミダゾキノリン化合物およびその使用
US4411909A (en) [(2-Oxo-3-tetrahydrothienylcarbamoyl)-alkylthio] acetic acids, their salts and esters, a process for preparation thereof and the pharmaceutical compositions containing same
MX2014001551A (es) Inhibicion de canal ionico del potencial receptor transitorio a1 (trpa1).
JPS6328411B2 (enExample)
US10322124B2 (en) 6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases
SE505258C2 (sv) Nya dihydrokloridhydrat av 7-(]0a]-(2aminotiazol-4-yl)-]0a]- (Z)-metoxiiminoacetamido)-3-((1-metylpyrrolidino)-metyl)-3- cefem-4-karboxylsyra i kristallin form
US4132802A (en) Benzoic acid derivative and benzenesulfonic acid mucolytic process
CA1119610A (en) L-cysteine derivatives and medicaments containing them
US3898338A (en) 1,4-Bis-acylpiperazine mucolytic process
JPS60132999A (ja) エリスロマイシンのチオ−ル誘導体、その製造方法並びにそれを含有する組成物
US3965167A (en) Crystalline ammonium N-acetyl-L-cysteinate and mucolytic process
KR860001311B1 (ko) 2-테노일메르캅토프로피온일글리신과 치환 히드록시벤젠류와의 에스테르 제조방법
JP7366074B2 (ja) ３”，５”－ジアルコシベンゾイル－３’－アミノ－３’－デオキシアデノシン－５’－三リン酸及びその医薬用途
US4178301A (en) Benzoic acid derivatives
US20040034058A1 (en) Novel pharmaceutical formulation suitable for nebulisation
HU201930B (en) Process for producing azoniaspiro(notropanol) esters and pharmaceutical compositions comprising same
CN119345161A (zh) 一种丙酮酸钠雾化吸入制剂及其制备方法和应用
WO2022157744A1 (en) Composition in form of dry powder for inhalation comprising a hyaluronic acid and a chondroitin sulfate, use of the composition and inhaler device containing the composition
JPS642596B2 (enExample)
JPS60346B2 (ja) Ｓ−（３−メチル−２−ブテニル）システインならびにその製法
JPH0374219B2 (enExample)
JPH05194588A (ja) Ｎ−（５−オキソ（又はチオキソ）−ｌ−プロリル）−ｌ−システイン、その誘導体、これらの化合物の製造法およびこれらの化合物を含有する医薬組成物

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7806880-6

Effective date: 19920109

Format of ref document f/p: F